Blood pressure and risk of cancer: a Mendelian randomization study

Abstract

Background Previous large observational cohort studies showed higher blood pressure (BP) positively associated with cancer. We used Mendelian randomization (MR) to obtain less confounded estimates of BP on total and site-specific cancers. Methods We applied replicated genetic instruments for systolic and diastolic BP to summary genetic associations with total cancer (37387 cases, 367856 non-cases) from the UK Biobank, and 17 site-specific cancers (663–17881 cases) from a meta-analysis of the UK Biobank and the Kaiser Permanente Genetic Epidemiology Research on Adult Health and Aging. We used inverse-variance weighting with multiplicative random effects as the main analysis, and sensitivity analyses including the weighted median, MR-Egger and multivariable MR adjusted for body mass index and for smoking. For validation, we included breast (Breast Cancer Association Consortium: 133384 cases, 113789 non-cases), prostate (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome Consortium: 79194 cases, 61112 non-cases) and lung (International Lung and Cancer Consortium: 10246 cases, 38295 non-cases) cancer from large consortia. We used asthma as a negative control outcome. Results Systolic and diastolic BP were unrelated to total cancer (OR 0.98 per standard deviation higher [95% confidence interval (CI) 0.89, 1.07] and OR 1.00 [95% CI 0.92, 1.08]) and to site-specific cancers after accounting for multiple testing, with consistent findings from consortia. BP was nominally associated with melanoma and possibly kidney cancer, and as expected, not associated with asthma. Sensitivity analyses using other MR methods gave similar results. Conclusions In contrast to previous observational evidence, BP does not appear to be a risk factor for cancer, although an effect on melanoma and kidney cancer cannot be excluded. Other targets for cancer prevention might be more relevant.

Evidence for a causal relationship between psoriasis and cutaneous melanoma: a bidirectional two-sample Mendelian randomized study

“…Finally, when palindromic SNPs existed, we used the allele frequency information to infer the forward-strand alleles. We used a curated genotype-phenotype database (PhenoScanner) to search for associations between variants used to detect each instrumental variable and other traits that may represent pleiotropic pathways; specific examples are traits associated with hypertension and telomere length, which are recognized risk factors for cutaneous melanoma ( 18 , 19 ). Variants associated with these and other traits were excluded from sensitivity analysis (using a software default threshold of P< 5 × 10 – 8).…”

Causal association between gut microbiota and intrahepatic cholestasis of pregnancy: mendelian randomization study

“…Mendelian randomization (MR) is an approach integrating summary data of genome-wide association studies (GWAS) to estimate the causal link between risk factors and outcomes [ 11 ]. Genetic polymorphisms that are randomly assigned at conception are used in MR design as instrumental variables, which can fill in the gaps in the evidence by reducing confounding variables [ 12 ]. MR method must conform to three important assumptions.…”

Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)

“…There is inconsistent evidence regarding the association of hypertension and cancer risk. 9 , 10 In observational studies, hypertension was associated with increased cancer risk. However, in a Mendelian randomization analysis using genetic variants to explore causality, blood pressure did not appear to be a causal risk factor for cancer.…”

“…However, in a Mendelian randomization analysis using genetic variants to explore causality, blood pressure did not appear to be a causal risk factor for cancer. 10 Renin-angiotensin-system (RAS) plays a pivotal role in the regulation of blood pressure through formation of angiotensin-II which is one of the most potent vasoconstrictors with pro-inflammatory effects. Experimental and clinical studies suggested that gluco-lipotoxicity could activate angiotensin-II with increased angiogenesis and cellular adhesion, invasion and proliferation which might promote cancer risk.…”